结合体外治疗与病原体血吸和细胞导向免疫调节策略:两种病例系列
Junya Hagiwara1, Linda E Sousse1, Fadi Abouzahr2
1Institute for Extracorporeal Life Support, San Antonio, TX, USA.
Case reports in nephrology and dialysis
|December 8, 2025
概括
赛拉夫100和选择性细胞突变装置 (SCD) 的联合使用显示出在败血症管理中的潜力. 一名患者康复了,但另一名患者屈服了,强调需要仔细选择患者,并进一步研究这些体外血液净化方法.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 传染病 传染病 传染病
背景情况:
- 败血症是一种危及生命的疾病,死亡率高.
- 身体外血液净化 (EBP) 提供了辅助性败血症治疗.
- 塞拉夫100可以过病原体;SCD可以中和白细胞.
研究的目的:
- 介绍关于Seraph 100和SCD的联合使用的案例.
- 探索结合EBP在严重感染中的有效性和挑战.
主要方法:
- 两个案例报告详细介绍了Seraph 100和SCD应用程序的结合.
- 血液动力学,氧化和功能监测.
- 对患者结果和治疗策略的审查.
主要成果:
- 一名患有败血性休克和AKI的患者在Seraph 100和SCD后完全康复.
- 另一位患有流感和多器官衰竭的患者尽管结合了EBP和ECMO,但死亡.
- 结果各不相同,表明潜在的好处和局限性.
结论:
- 组合EBP (Seraph 100和SCD) 是有前途的,但需要小心选择患者.
- 最佳的时间和治疗策略对于改善结果至关重要.
- 进一步的研究是必要的,以验证结合EBP在重症监护中的有效性.
相关概念视频
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
178
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
178
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cell-mediated Immune Responses
83.3K
Overview
83.3K


